W

William R. Sellers

Broad Institute

ORCID: 0000-0002-3539-9803

Publishes on PI3K/AKT/mTOR signaling in cancer, Melanoma and MAPK Pathways, Fibroblast Growth Factor Research. 827 papers and 85.4k citations.

PubIndex Score98Top 2%How it's scored

🌟#10 Current Senior Leader in HER2/EGFR in Cancer Research

827Publications

85.4kTotal Citations

#10in HER2/EGFR in Cancer Research

First publication: 1969First senior author: 1990

PI3K/AKT/mTOR signaling in cancer Melanoma and MAPK Pathways Fibroblast Growth Factor Research Cancer Genomics and Diagnostics Epigenetics and DNA Methylation

Top publicationsby citations

<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

J. Guillermo Paez, Matthew Meyerson, Pasi A. Jänne et al.|Science|2004

Cited by 9.4k

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Ross L. Levine, D. Gary Gilliland, Martha Wadleigh et al.|Cancer Cell|2005

Cited by 3k

Gene expression correlates of clinical prostate cancer behavior

Dinesh Singh, William R. Sellers, Phillip G. Febbo et al.|Cancer Cell|2002

Cited by 2.5k

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

Levi A. Garraway, William R. Sellers, Danny A. Milner et al.|Nature|2005

Cited by 1.5k

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

Cory M. Johannessen, Levi A. Garraway, Jesse S. Boehm et al.|Nature|2010

Cited by 1.4k